Hossein Borghaei, MD of Fox Chase Discusses new data on lurbinectedin
PharmaMar will submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Hossein Borghaei, MD of Fox Chase discusses the new data released and what advantages ...
Author: PharmaMar
Added: 08/21/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts